Lipocine Inc.

NASDAQ: LPCN · Real-Time Price · USD
3.03
-0.01 (-0.33%)
At close: Aug 15, 2025, 3:59 PM
3.04
0.33%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lipocine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
11.2M -2.85M 500K 16.14M
Cost of Revenue
7.35M 10.18M n/a n/a
Gross Profit
3.85M -13.03M 500K 16.14M
Operating Income
-1.16M -17.93M -12.12M 3.15M
Interest Income
1.15M 1.37M 572.58K 67.7K
Pretax Income
9.03K -16.35M -10.76M -634.2K
Net Income
8.35K -16.35M -10.76M -634.4K
Selling & General & Admin
5M 4.9M 4.06M 5.33M
Research & Development
7.35M 10.18M 8.56M 7.67M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
12.35M 15.08M 11.8M 16.64M
Interest Expense
n/a n/a 27.1K 203.29K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.35M 15.08M 11.8M 16.64M
Income Tax Expense
681.00 755.00 681.00 200.00
Shares Outstanding (Basic)
5.34M 5.27M 4.99M 3.3M
Shares Outstanding (Diluted)
5.42M 5.27M 5.26M 5.15M
EPS (Basic)
0.00 -3.14 -2.15 -0.19
EPS (Diluted)
-0.00 -3.14 -2.05 -0.12
EBITDA
-1.11M -17.9M -10.72M -430.53K
EBIT
-1.16M -17.93M -10.73M -430.91K
Depreciation & Amortization
41.11K 28.66K 9.45K 380.00